The South and Central America eyelashes enhancing agents market is expected to reach US$ 25.99 million by 2028 from an estimated value of US$ 18.32 million in 2021; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028.
The market's growth is due to the rising prevalence of eye diseases and online availability and purchase of products. However, side effects such as skin allergies, swelling, hyperpigmentation, and excessive growth are hampering the market growth.
According to the American Optometric Association, blepharitis is an eyelid inflammation that causes redness, irritation, and itching to the eyes and the formation of dandruff-like scales on the eyelashes. It can further lead to the blurring of vision, missing or misdirected eyelashes, and inflammation of the cornea. According to studies cited in the review of Optometry, a huge number of Americans suffer from itchy eyes caused by allergies. As per experts, blepharitis is seen in people of all ages, ethnicities, and gender, but it is more common among individuals of age 50 and above. According to the survey conducted by the American Academy of Ophthalmology, 37–47% of patients had a sign of blepharitis in the US. Moreover, based on the estimation of Lemp et al, 86% of patients with dry eyes have concomitant blepharitis, while more than 25 million Americans suffer from blepharitis. Companies are focused on developing topical products for the cosmetic treatment of eyelashes. For instance, LATISSE, i.e., 0.03% bimatoprost ophthalmic solution, is an FDA-approved drug to increase eyelashes' length, thickness, and darkness in patients with hypotrichosis. Thus, the rising prevalence of eye disease is driving the growth of eyelash-enhancing agents' as these products are prescribed to grow thicker and longer eyelashes.
The changing and busy lifestyles of the consumers in Latin American countries led to a rise in demand for multifunctional beauty and personal care products as the consumers are following holistic approaches to beauty and health care. As a result, the region holds significant opportunities for various cosmetics brands to innovate and expand. Skincare and hair care are the major growing segments in this region. Moreover, natural and organic cosmetic products are gaining high prominence due to escalating preferences for luxury personal care brands.
South and Central America Eyelashes Enhancing Agents Market Revenue and Forecast to 2028 (US$ Mn)
SOUTH AND CENTRAL AMERICA EYELASHES ENHANCING AGENTS MARKET SEGMENTATION
The South and Central America eyelashes enhancing agents market, based on type has been segmented into curling, lengthening, volumizing, and others. The South and Central America eyelashes enhancing agents market, based on content type has been segmented into bimatoprost, lash-building serum, and others. The South and Central America eyelashes enhancing agents market, based on application, has been sub-segmented into repairing damaged eyelashes and nourishing. Geographically, the South and Central America eyelashes enhancing agents market can be sub-divided into as Brazil, Argentina and Rest of South and Central America.
AbbVie Inc., Estée Lauder Inc, L'Oréal S.A. and SkinGen International, Inc.are among the leading companies operating in the South and Central America eyelashes enhancing agents market.
South and Central America Eyelashes Enhancing Agents Market Strategic Insights
South and Central America Eyelashes Enhancing AgentsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 18.32 Million |
| Market Size by 2028 | US$ 25.99 Million |
| CAGR (2021 - 2028) | 5.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
South and Central America Eyelashes Enhancing Agents Market Country and Regional Insights
